SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-001195
Filing Date
2024-01-03
Accepted
2024-01-03 17:30:50
Documents
1
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6152
  Complete submission text file 0000950170-24-001195.txt   7812
Mailing Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 225 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALAUNOS THERAPEUTICS, INC. 2617 BISSONNET ST, SUITE 225 HOUSTON TX 77005
Business Address
Hogue Dale Curtis Jr. (Reporting) CIK: 0002006649 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 24508338